Ankur Drugs & Pharma Q4 net profit up 140%
Ankur Drugs & Pharma Ltd, one of the top pharmaceutical companies engaged in manufacturing of pharmaceutical formulations for leading Indian companies has posted excellent results for the final quarter of the 2008 fiscal. The company posted a PAT of Rs 19.96 crores for the quarter ended March 31, 2008, a hop of 140% over Rs 8.28 crores for the same quarter last fiscal. Net Income rose 120% to Rs 207.50 crore, up from Rs 94.40 crores in the last fiscal.
The company’s Net Sales for FY08 stands at Rs 673.65 crore, against Rs 373.23 crore last year. For the year ended March 31, 2008, PAT climbed 97% YoY to Rs 64.72 crore from Rs 32.73 crore. The fully diluted Earnings Per Share (EPS) for the year ending March 31, 2008 stands at Rs 37.47, up from Rs 24.13 last year.
Announcing the results, Mr. Purnandu Jain, Chairman & Managing Director of Ankur Drugs & Pharma Ltd. said, “We are quite pleased with our present turnover and going forward, we hope to maintain the growth pitch.”
Sourced From: Concept Public Relations India Pvt. Ltd
Tags: calls, daytrading, free calls, intraday, tips
Similar Posts:
Latest Query
- by Sam
Market Stats
Search Our Archives
Research Desk
- Stocks Trading above their 50 day moving average - DMA In Stock Research
- Download free Ebooks based on Technical Analysis In Personal Training
- TOP 100 Stocks with the Highest P/E as on July 14th, 2013 In Stock Research
- TOP 100 Stocks with the Lowest P/E as on July 14th, 2013 In Stock Research
- Charting Pathsala - Your guide to Techincals In Technical Analysis
